Review article
Indications for and limitations of portal vein embolization before major hepatic resection for hepatobiliary malignancy

https://doi.org/10.1016/S1055-3207(02)00039-XGet rights and content

Section snippets

Technique

The goal of PVE is to redistribute portal flow toward the segments of liver that will remain after surgery. To avoid limiting liver regeneration, recanalization of the portal occlusion should be avoided. Embolization of portal branches must be as complete as possible and should result in occlusion of the entire portal tree to prevent the development of intrahepatic portoportal collaterals [6]. Embolization usually is performed with the patient under conscious sedation when the procedure is done

Materials for embolization

There is no general consensus regarding which embolic material should be used for PVE. Because published series rarely include more than 50 patients, it is difficult to draw any definitive conclusions as to which agent leads to superior rates or degrees of hypertrophy.

Gelatin sponge was used in the initial series, but this material frequently resulted in portal recanalization as early as 2 weeks after PVE [5], [8]. At 4 weeks after PVE, gelatin sponge seems to be less efficient than other

Measurement of future liver remnant volumes after PVE

Computed tomographic scanning with volumetrics most commonly is used to determine whether PVE is necessary before hepatic resection and to determine whether adequate hypertrophy of the future liver remnant (FLR) has occurred. The new-generation helical and multi–slice helical CT scanners allow accurate and reproducible volumetric measurement of the liver [19], [20]. These measurements are made by delineating and drawing the contours of the different segments and calculating the liver volume

Liver metastases

Hepatic resection offers the only chance of long-term survival in patients with liver metastases from colorectal cancer, resulting in 5-year survival rates ranging from 25% to 40% [26], [27]. Only 5% to 10% of patients with colorectal liver metastases are considered candidates for surgery, because most of these patients have multi-segment involvement [27]. Because of the dismal overall survival of patients with unresectable liver metastases from colorectal carcinoma, different techniques have

Future prospects

Portal vein embolization has proved to be effective in terms of regeneration and functional volume gain of the FLR. Three issues remain unclear, however. The indications for the procedure vary depending on the underlying liver status (ie, cholestatic, cirrhotic, or healthy). In patients with chronic liver disease, PVE can be considered in all patients before a major hepatic resection to reduce morbidity and to extend indications. In patients with liver metastases, PVE must be limited to

Summary

Portal vein embolization is a promising adjunctive tool in liver surgery; however, the understanding of liver regeneration and PVE is still in its infancy. Refinement in patient selection criteria and methods to evaluate hepatic hypertrophy and function should increase the potential indications for PVE and expand the field of major liver surgery.

First page preview

First page preview
Click to open first page preview

References (49)

  • J.L. Cameron et al.

    Management of proximal cholangiocarcinomas by surgical resection and radiotherapy

    Am J Surg

    (1990)
  • M. Nagino et al.

    Right or left trisegment portal vein embolization before hepatic trisegmentectomy for hilar bile duct carcinoma

    Surgery

    (1995)
  • M. Nagino et al.

    Right trisegment portal vein embolization for biliary tract carcinoma: technique and clinical utility

    Surgery

    (2000)
  • E.K. Abdalla et al.

    Portal vein embolization: rationale, technique and future prospects

    Br J Surg

    (2001)
  • K. Takayasu et al.

    Hepatic lobar atrophy following obstruction of the ipsilateral portal vein from hilar cholangiocarcinoma

    Radiology

    (1986)
  • H. Kinoshita et al.

    Preoperative portal vein embolization for hepatocellular carcinoma

    World J Surg

    (1986)
  • M. Makuuchi et al.

    Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report

    Surgery

    (1990)
  • A.L. Denys et al.

    Failure of right portal vein ligation to induce left lobe hypertrophy due to intrahepatic portoportal collaterals: successful treatment with portal vein embolization

    AJR Am J Roentgenol

    (1999)
  • M. Nagino et al.

    Percutaneous transhepatic portal embolization using newly devised catheters: preliminary report

    World J Surg

    (1993)
  • D. Di Stefano et al.

    Incidents and complications after percutaneous portal vein embolization

    J Radiol

    (2000)
  • D. Azoulay et al.

    Right portal vein embolization in preparation for major hepatic resection

    J Am Coll Surg

    (1995)
  • T. Kaneko et al.

    Experimental study of new embolizing material for portal vein embolization

    Hepatogastroenterology

    (2000)
  • T. Matsuoka

    Experimental studies of intrahepatic portal vein embolization and embolic material

    Nippon Igaku Hoshasen Gakkai Zasshi

    (1989)
  • D. Azoulay et al.

    Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver

    Ann Surg

    (2000)
  • Cited by (28)

    • Portal Venous Interventions: How to Recognize, Avoid, or Get Out of Trouble in Transjugular Intrahepatic Portosystemic Shunt (TIPS), Balloon Occlusion Sclerosis (ie, BRTO), and Portal Vein Embolization (PVE)

      2018, Techniques in Vascular and Interventional Radiology
      Citation Excerpt :

      A major limiting factor when considering surgical resection is the capacity of the future liver remnant (FLR) to sustain the liver functions and avoid liver failure. FLR of less than 20% in normal livers, 30% in patients subjected to heavy chemotherapy, and 40% in chronic liver disease, respectively, are associated with increased incidence of liver failure.70 PVE has become a standard procedure to increase the FLR by diverting the portal blood flow away from the tumor-bearing liver.

    • Chapter 24 - Intraoperative and immediate postoperative management

      2017, Blumgart's Surgery of the Liver, Biliary Tract and Pancreas: Sixth Edition
    • Chapter 108C - Preoperative portal vein embolization: Technique and results

      2016, Blumgart's Surgery of the Liver, Biliary Tract and Pancreas: Sixth Edition
    • Liver segmentation: Practical tips

      2014, Diagnostic and Interventional Imaging
      Citation Excerpt :

      The interventional radiologist or surgeon should have good knowledge of it before the intervention, whether simple or complex, in order to decide on the most appropriate technique, anticipate any additional stages and also reduce the risk of intra or post-intervention complications. As mentioned above, portal embolisation consists of embolising the portal branches of the liver that will be removed about 4 weeks before the surgery, in order to increase the volume of the liver left in place, by redistribution of the portal blood flow [45,49,50]. Portal anatomic variations increase the complexity of this procedure.

    • Preoperative portal vein embolization: Technique

      2012, Blumgart's Surgery of the Liver, Biliary Tract and Pancreas
    • Intraoperative and immediate postoperative management

      2012, Blumgart's Surgery of the Liver, Biliary Tract and Pancreas
    View all citing articles on Scopus
    View full text